Speed and safety in drug development have always been in tension. The faster you move, the more risk you introduce. The more careful you are, the longer it takes to bring treatments to the people who need them or your competition might just beat you. What’s changing now is how that balance is managed—and it … Read more
The rush to adopt AI has outpaced most teams’ ability to build systems that hold up under pressure. Short-term performance looks good in a demo, but when regulations tighten, data shifts, or scale demands real structure, the cracks show up fast. That’s where the real cost starts to creep in—through rework, patching, or tools that … Read more
You train the model. It checks out in testing. Then things slow down. Performance drops in production. Teams start firefighting. That early momentum gives way to friction—technical debt, unclear handoffs, and systems that don’t hold up under pressure. It’s a common story, especially in environments that move fast. I’m Robb Fahrion, CEO of a lead … Read more
I’m Robb Fahrion, CEO of a demand generation agency, Partner of an AI consulting company, and an investor focused on emerging tech with long-term staying power. Over the last few years, I’ve spent time exploring where AI is headed—not just in terms of what gets headlines, but what quietly shapes the future of enterprise systems … Read more
